Global Glycobiology
Market, By Product Type (Instruments, Enzymes (Galactosidases (Fucosidases,
Chitinases, Acetylgalactosaminidase, Heparinase, PNGase F, and Others), GlcNAc
Transferases (Acetylglucosaminyltransferase, Exostosin, and Others),
Fucosyltransferases, GalNAc Transferases, Galactosyl Transferases,
Glucuronosyltransferases, Glucosyltransferases, Pentosyltransferases,
Carbohydrate Kinases, Neuraminidases, Sialyltransferases, and Others),
Consumables, Reagents & Kits), By Application (Drug Discovery and
Development, Diagnostic Applications (Oncology, Immunology, and Others), Industrial
Application, Therapeutic Application (Oncology, Immunology, and Others), and
Others), By End User, (Pharmaceutical Companies, Research Laboratories,
Hospitals, Diagnostic Centers, Contract Research Organizations, Biotechnology
Companies, Academic Institutes, and Others), By Region (North America, Latin
America, Europe, Asia Pacific, Middle East, and Africa), is estimated to be
valued at US$ $ 1,165.3 Mn in 2020 and is expected to exhibit a CAGR of 12.8%
during the forecast period (2020-2027), as highlighted in a new report published
by Coherent Market Insights.
The increasing number of product
launches such as mass spectrometry devices, high profile liquid chromatography
(HPLC) devices, and others is expected to drive the global glycobiology market
growth. For instance, in May 2019, Shimadzu Corporation announced the launch of
Novel Shimadzu MALDImini-1 Digital Ion Trap Mass Spectrometer, which provides
fast, high-sensitive measurements through an ultra-compact design for clinical
and laboratory research.
Global Glycobiology Market–
Impact of Coronavirus (COVID-19) Pandemic
Supply chain and manufacturing
activities in India, Italy, Spain, the U.K., and the U.S. have been disrupted
due to lockdowns implemented by various governments in the past few months,
while countries such as Saudi Arabia, UAE, Egypt, and others are facing
problems with regards to transportation of drug products. The coronavirus or
COVID-19 outbreak that started from Wuhan, China, has spread across continents,
affecting various industries globally. Supply of key materials has been
severely disrupted due to forced quarantine and lack of labor and raw
materials.
* The sample copy includes: Report Summary, Table of
Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copy
of this report: https://www.coherentmarketinsights.com/insight/request-sample/3639
As the supply link between
regional warehouses is not smooth, the transportation of raw materials between
various regions cannot be carried out successfully. This shortage of raw
materials and components have affected the supply chain of the global
glycobiology market. The COVID-19 pandemic has impacted the global economy and
in turn, the glycobiology market.
Browse 43 Market Data Tables and
14 Figures spread through 195 Pages and in-depth TOC on “Global Glycobiology
Market”- Forecast to 2027, Global
Glycobiology Market, By Product Type (Instruments, Enzymes (Galactosidases
(Fucosidases, Chitinases, Acetylgalactosaminidase, Heparinase, PNGase F, and
Others), GlcNAc Transferases (Acetylglucosaminyltransferase, Exostosin, and
Others), Fucosyltransferases, GalNAc Transferases, Galactosyl Transferases,
Glucuronosyltransferases, Glucosyltransferases, Pentosyltransferases,
Carbohydrate Kinases, Neuraminidases, Sialyltransferases, and Others),
Consumables, Reagents & Kits), By Application (Drug Discovery and
Development, Diagnostic Applications (Oncology, Immunology, and Others),
Industrial Application, Therapeutic Application (Oncology, Immunology, and
Others), and Others), By End User, (Pharmaceutical Companies, Research
Laboratories, Hospitals, Diagnostic Centers, Contract Research Organizations,
Biotechnology Companies, Academic Institutes, and Others), By Region (North
America, Latin America, Europe, Asia Pacific, Middle East, and Africa).
Moreover, rise in research and
development related to oligosaccharides is also expected to aid in growth of
the global glycobiology market over the forecast period. For instance, in
February 2020, researchers from University of Kentucky, U.S. reported the use
of a high-throughput assay to determine the effect of various
post-translational modifications of the Chondroitin sulfate
proteoglycansaggrecan upon neurite outgrowth from NS-1 cells.
Browse Research
Report: https://www.coherentmarketinsights.com/market-insight/glycobiology-market-3639
Key Takeaways of the Global
Glycobiology Market:
The global glycobiology market is
expected to exhibit a CAGR of 12.8% during the forecast period owing to the
increasing focus on manufacturing anti-cancer drugs, this is expected to boost
growth of the market. For instance, in January 2020, researchers from
Universidade do Porto, Portugal, assessed the role of O-glycosylation using
glycoengineered gastric cancer models in the detection of CD44v9 – a major
protein splice variant isoforms expressed in human gastrointestinal cancer
cells—using monoclonal antibodies.
Among Applications, Drug
discovery and development segment is accounted for the largest market share in
global glycobiology market in 2020. Moreover, investments on drug discovery and
development by the key players operating in the market is expected to drive the
segment growth over the forecast period. For instance, Merck invested around
US$ 9,872 million and US$ 9,752 million on research and development in 2019 and
2018, respectively.
Among the regions, Asia Pacific
is estimated to exhibit higher CAGR in the global glycobiology market over the
forecast period. For instance, in June 2019, a group of Japanese scientists
from different universities and research institutes discovered a novel SGL
enzyme ((TfSGLr) from a soil fungus, Talaromyces funiculosus. This enzyme TfSGL
protein (TfSGLr) was found to break down both linear and cyclic β-1,2-glucans
for carbohydrate metabolism.
Major players operating in the
global glycobiology market are Merck & Co., Inc., Bio-Techne Corporation,
Bruker Corporation, Thermo Fisher Scientific Inc., Shimadzu Corporation,
Plexera LLC, New England Biolabs, and Agilent Technologies, Inc.
Buy-Now this research
report: https://www.coherentmarketinsights.com/insight/buy-now/3639
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis, consulting
services, and competitive analysis through various recommendations related to
emerging market trends, technologies, and potential absolute dollar
opportunity.
Contact
Us:
mailto:sales@coherentmarketinsights.com
U.S.
Office:
Name: Mr. Shah
Coherent
Market Insights 1001 4th Ave,
# 3200
Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737
No comments:
Post a Comment